Researchers continue to excited about the medication , a groundbreaking dual agonist showing remarkable outcomes in early trials for weight reduction . It functions by targeting both hormones : GLP-1 and https://nellsvqo504532.howeweb.com/41412359/the-new-prospect-for-size-reduction